Although the correlation between BDNF and HD is still under investigation, it is evident that reinstating BDNF levels in the striatum or stimulating its downstream signaling pathways could offer therapeutic potential in mitigating the functional impairments experienced by individuals with HD. This evidence concerns the gene BDNF and Huntington disease.